Treatment options in type-2 low asthma

Treatment options in type-2 low asthma

Monoclonal antibodies targeting IgE or the type-2 cytokines IL-4, IL-5 and IL-13 are proving highly effective in reducing exacerbations and symptoms in people with severe allergic and eosinophilic asthma respectively. However, these therapies are not appropriate for 30–50% of patients in severe asth...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Hinks, TSC, Levine, SJ, Brusselle, GG
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	European Respiratory Society 2020

Eitemau Tebyg

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
gan: Couillard, S, et al.
Cyhoeddwyd: (2021)

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?
gan: Hinks, TSC, et al.
Cyhoeddwyd: (2022)

Boosting MAIT cells as immunotherapy: Context is everything
gan: Hinks, TSC
Cyhoeddwyd: (2020)

Azithromycin for mild-to-moderate COVID-19 - Authors' reply
gan: Hinks, TSC
Cyhoeddwyd: (2021)

A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)
gan: Couillard, S, et al.
Cyhoeddwyd: (2021)

ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma—implications for COVID-19
gan: Bradding, P, et al.
Cyhoeddwyd: (2020)

Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis
gan: Oliver, ME, et al.
Cyhoeddwyd: (2021)

Is there a role for type 2 CD8+ T cells in patients with steroid-resistant asthma?
gan: Gelfand, EW, et al.
Cyhoeddwyd: (2019)

Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma
gan: Couillard, S, et al.
Cyhoeddwyd: (2021)

Azithromycin in viral infections
gan: Oliver, ME, et al.
Cyhoeddwyd: (2020)

Small airways in asthma: treatment options
gan: K. A. Zykov
Cyhoeddwyd: (2013-12-01)

MAIT cells and the microbiome
gan: Jabeen, MF, et al.
Cyhoeddwyd: (2023)

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
gan: Lavoie, G, et al.
Cyhoeddwyd: (2024)

The upper and lower airway microbiome in severe asthma
gan: Jabeen, M, et al.
Cyhoeddwyd: (2022)

Unconventional Treatment Options in Severe Asthma: An Overivew
gan: Hoan Linh Banh
Cyhoeddwyd: (2011-10-01)

Biological treatment options for severe asthma in Poland
gan: Maciej Superson, et al.
Cyhoeddwyd: (2024-05-01)

Azithromycin in uncontrolled asthma
gan: Brusselle, G, et al.
Cyhoeddwyd: (2017)

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
gan: Crossingham, I, et al.
Cyhoeddwyd: (2020)

Treatment options for severe bronchial asthma: reality and prospects
gan: N. M. Nenasheva
Cyhoeddwyd: (2013-12-01)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
gan: Howell, I, et al.
Cyhoeddwyd: (2023)

Biological functions of MAIT cells in tissues
gan: Klenerman, P, et al.
Cyhoeddwyd: (2020)

Editorial: MAIT cells come of age
gan: Corbett, AJ, et al.
Cyhoeddwyd: (2023)

Cytometric gating stringency impacts on studies of type 2 innate lymphoid cells in asthma
gan: Hinks, T, et al.
Cyhoeddwyd: (2017)

Biological treatment of severe asthma: new objectives and new treatment options
gan: N. M. Nenasheva
Cyhoeddwyd: (2019-12-01)

Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?
gan: Kumar, K, et al.
Cyhoeddwyd: (2020)

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)
gan: Couillard Castonguay, S, et al.
Cyhoeddwyd: (2022)

Severe asthma and the omalizumab option
gan: Johnston Chambless, et al.
Cyhoeddwyd: (2008-05-01)

New targets for type 2-low asthma
gan: Quang Luu Quoc, et al.
Cyhoeddwyd: (2024-03-01)

High-altitude sojourn: a treatment option in allergic asthma
gan: Swiss Medical Weekly
Cyhoeddwyd: (2013-07-01)

Severe refractory asthma: current treatment options and ongoing research
gan: Francesco Menzella, et al.
Cyhoeddwyd: (2018-12-01)

From spirometry to spatial omics in pursuit of asthma endotypes
gan: Hinks, T
Cyhoeddwyd: (2022)

New therapy options for patients with eosinophilic type of severe bronchial asthma
gan: G. L. Ignatova, et al.
Cyhoeddwyd: (2020-01-01)

Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
gan: Crossingham, I, et al.
Cyhoeddwyd: (2021)

Chronic orchialgia: evaluation and discussion of treatment options
gan: Laurence Levine
Cyhoeddwyd: (2010-10-01)

CD8+ Tc2 cells: underappreciated contributors to severe asthma
gan: Hinks, T, et al.
Cyhoeddwyd: (2019)

Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
gan: Crossingham, I, et al.
Cyhoeddwyd: (2021)

Tiotropium as an Add-on Treatment Option for Severe Uncontrolled Asthma in Preschool Patients
gan: Zielen S, et al.
Cyhoeddwyd: (2021-01-01)

Tezepelumab as an Emerging Therapeutic Option for the Treatment of Severe Asthma: Evidence to Date
gan: Dorey-Stein ZL, et al.
Cyhoeddwyd: (2021-01-01)

The role of interleukin-17 in asthma: a protective response?
gan: Hynes, G, et al.
Cyhoeddwyd: (2020)

From spirometry to spatial omics in pursuit of asthma endotypes
gan: Timothy S. C. Hinks
Cyhoeddwyd: (2022-09-01)